- Home
- THCH vs NSPR Comparison
THCH vs NSPR Comparison
Compare THCH & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THCH
- NSPR
- Stock Information
- Founded
- THCH 2018
- NSPR 2005
- Country
- THCH China
- NSPR United States
- Employees
- THCH N/A
- NSPR N/A
- Industry
- THCH Blank Checks
- NSPR Medical/Dental Instruments
- Sector
- THCH Finance
- NSPR Health Care
- Exchange
- THCH Nasdaq
- NSPR Nasdaq
- Market Cap
- THCH 73.0M
- NSPR 79.7M
- IPO Year
- THCH N/A
- NSPR N/A
- Fundamental
- Price
- THCH $2.63
- NSPR $2.56
- Analyst Decision
- THCH
- NSPR Strong Buy
- Analyst Count
- THCH 0
- NSPR 2
- Target Price
- THCH N/A
- NSPR $4.75
- AVG Volume (30 Days)
- THCH 9.8K
- NSPR 47.5K
- Earning Date
- THCH 06-04-2025
- NSPR 05-09-2025
- Dividend Yield
- THCH N/A
- NSPR N/A
- EPS Growth
- THCH N/A
- NSPR N/A
- EPS
- THCH N/A
- NSPR N/A
- Revenue
- THCH $190,593,087.00
- NSPR $7,027,000.00
- Revenue This Year
- THCH N/A
- NSPR $28.93
- Revenue Next Year
- THCH N/A
- NSPR $172.18
- P/E Ratio
- THCH N/A
- NSPR N/A
- Revenue Growth
- THCH N/A
- NSPR 12.96
- 52 Week Low
- THCH $2.15
- NSPR $2.07
- 52 Week High
- THCH $6.00
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- THCH 43.75
- NSPR 49.83
- Support Level
- THCH $2.61
- NSPR $2.40
- Resistance Level
- THCH $2.84
- NSPR $2.79
- Average True Range (ATR)
- THCH 0.13
- NSPR 0.16
- MACD
- THCH 0.01
- NSPR 0.02
- Stochastic Oscillator
- THCH 48.94
- NSPR 60.42
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. It is also the operator and developer of Popeyes brand in Mainland China. The firm has two reportable segments; Tim Hortons which generates key revenue, and Popeyes. The company's revenue is derived from its operations in the PRC.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.